Patents by Inventor Linda Anderson-Mauser

Linda Anderson-Mauser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Water color pigment solutions for use with reflectance-based diagnostic analyzers
    Patent number: 11385103
    Abstract: Provided herein are color charts and water color pigment solutions useful, for example, in the calibration of reflectance-based diagnostic analyzers.
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: July 12, 2022
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Gary W. Rheinheimer, Chris T. Zimmerle, Linda Anderson-Mauser
  • Water Color Pigment Solutions For Use With Reflectance-Based Diagnostic Analyzers
    Publication number: 20210199506
    Abstract: Provided herein are color charts and water color pigment solutions useful, for example, in the calibration of reflectance-based diagnostic analyzers.
    Type: Application
    Filed: March 5, 2021
    Publication date: July 1, 2021
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Gary W. RHEINHEIMER, Chris T. ZIMMERLE, Linda ANDERSON-MAUSER
  • Water color pigment solutions for use with reflectance-based diagnostic analyzers
    Patent number: 10969279
    Abstract: Provided herein are color charts and water color pigment solutions useful, for example, in the calibration of reflectance-based diagnostic analyzers.
    Type: Grant
    Filed: January 5, 2017
    Date of Patent: April 6, 2021
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Gary W. Rheinheimer, Chris T. Zimmerle, Linda Anderson-Mauser
  • WATER COLOR PIGMENT SOLUTIONS FOR USE WITH REFLECTANCE-BASED DIAGNOSTIC ANALYZERS
    Publication number: 20190368940
    Abstract: Provided herein are color charts and water color pigment solutions useful, for example, in the calibration of reflectance-based diagnostic analyzers.
    Type: Application
    Filed: January 5, 2017
    Publication date: December 5, 2019
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Gary W. Rheinheimer, Chris T. Zimmerle, Linda Anderson-Mauser
  • Monoclonal antibodies for detection of urinary trypsin inhibitors
    Patent number: 7858758
    Abstract: Certain monoclonal antibodies are able to detect urinary trypsin inhibitors (UTIs) that are characteristic of disease in humans. In particular, the UTIs include AMBK, Bikunin, Uristatin, Uristatin-1, Uristatin-2, as defined herein, also including the fragments and aggregates thereof.
    Type: Grant
    Filed: June 24, 2008
    Date of Patent: December 28, 2010
    Assignee: Siemens Healthcare Diagnostics, Inc.
    Inventors: Michael J. Pugia, Linda Anderson-Mauser, Solomon H. Murphy, Ronald G. Sommer, Shannon Gleason
  • Monoclonal Antibodies for Detection of Urinary Trypsin Inhibitors
    Publication number: 20080312420
    Abstract: Certain monoclonal antibodies are able to detect urinary trypsin inhibitors (UTIs) that are characteristic of disease in humans. In particular, the UTIs include AMBK, Bikunin, Uristatin, Uristatin-1, Uristatin-2, as defined herein, also including the fragments and aggregates thereof.
    Type: Application
    Filed: June 24, 2008
    Publication date: December 18, 2008
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Michael J. Pugia, Linda Anderson-Mauser, Solomon H. Murphy, Ronald G. Sommer, Shannon Gleason
  • Monoclonal antibodies for detection of urinary trypsin inhibitors
    Patent number: 7419665
    Abstract: Certain monoclonal antibodies are able to detect urinary trypsin inhibitors (UTIs) that are characteristic of disease in humans. In particular, the UTIs include AMBK, Bikunin, Uristatin, Uristatin-1, Uristatin-2, as defined herein, also including the fragments and aggregates thereof.
    Type: Grant
    Filed: July 29, 2004
    Date of Patent: September 2, 2008
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Michael J. Pugia, Linda Anderson-Mauser, Solomon H. Murphy, Ronald G. Sommer, Shannon Gleason
  • Monoclonal antibodies for detection of urinary trypsin inhibitors
    Publication number: 20070020683
    Abstract: Certain monoclonal antibodies are able to detect urinary trypsin inhibitors (UTIs) that are characteristic of disease in humans. In particular, the UTIs include AMBK, Bikunin, Uristatin, Uristatin-1, Uristatin-2, as defined herein, also including the fragments and aggregates thereof.
    Type: Application
    Filed: July 29, 2004
    Publication date: January 25, 2007
    Applicant: Bayer Healthcare LLC
    Inventors: Micheal Pugia, Linda Anderson-Mauser, Solomon Murphy, Ronald Sommer, Shannon Gleason
  • Humanized antibody conjugates and related methods, assays, reagents, and kits
    Publication number: 20070014789
    Abstract: The invention provides synthetically and recombinantly-derived humanized antibody conjugates and related methods, diagnostic assays, reagents, and kits. In one embodiment, the invention provides humanized antibody conjugates comprising a human immunoglobulin fragment which is bound by a cross-linking functional group to a non-human antibody fragment (e.g., a non-human monoclonal antibody fragment) comprising an antigen-binding amino acid sequence.
    Type: Application
    Filed: July 14, 2006
    Publication date: January 18, 2007
    Applicant: Bayer HealthCare LLC
    Inventors: Linda Anderson-Mauser, Robert Dwyer, Mary Foltz
  • Diagnosis of Candida vaginitis by detecting D-arabinitol in vaginal fluid
    Patent number: 5360718
    Abstract: A method for the presumptive detection of Candida in vaginal fluid, thereby providing an aid to the diagnosis of Candida vaginosis. A sample of vaginal fluid is combined with a test composition comprising an indicator system that provides a chromogenic response in the presence of D-arabinitol; the detection of an elevated level of D-arabinitol indicating the presumptive presence of Candida. The test composition preferably comprises the enzyme D-arabinitol dehydrogenase, NAD, an electron transfer agent, and a chromogenic indicator.
    Type: Grant
    Filed: November 10, 1993
    Date of Patent: November 1, 1994
    Assignee: Miles Inc.
    Inventor: Linda Anderson-Mauser